Kashiwa (1)

MSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal Cancers (1)

Recruiting (1)

phase 1 (1)

Novartis Pharmaceuticals (1)

hro761 (1)

irinotecan (1)

tislelizumab (1)

biological (1)

drug (1)

Industry (1)

Interventional (1)

msihi or dmmr advanced unresectable or metastatic solid tumors, including colorectal cancers

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Recruiting

MSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal Cancers

May 2, 2023